Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

However, leukemia originates in the bone marrow and spreads through the blood, while lymphoma originates in the spleen or lymph nodes and spreads through the lymph vessels.Leukemia and lymphoma can ...

Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

Vδ1+ γδ T cells are tissue-resident lymphocytes that exert a unique and ... including acute myeloid leukemia, myelodysplastic syndrome, acute lymphoblastic leukemia, and others.

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

This lysis is the definitive goal of an immune therapy for AML by using a defined T-cell epitope peptide derived from a LAA. AML: Acute myeloid leukemia; CTL: Cytotoxic T lymphocyte; FasL ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...